LBG Awarded Grant to Develop a Global Health Cost Model Platform
LBG was recently awarded a grant by the Bill & Melinda Gates Foundation to develop an easy-to-use, web-based modeling tool for use in determining the cost of goods of pharmaceutical …
News
LBG Team Members Discuss Quality Requirements During Product Development in Newly Published Article
Written by LBG’s Lauren Schoukroun-Barnes, Ph.D., Dianne Cantara, Sarah DeDonder, Ph.D., and Dawn Speidel, “Pharmaceutical Manufacturing Quality Assurance Programs: Transitioning from Research and Development to the Clinic” was recently published in BioProcess International. The article …
LBG Engages with Thought Leaders and Experts to Advance Global Biotech Industry
Therapeutic frontiers, the business of biotech, regulatory and policy outlooks, and human capital are just a few of the trending topics of discussion at the BIO International Convention. LBG Partners …
Jim Beltzer and Joe Rininger Join Effort to Transform Medicine Through the Use of Cell and Gene Therapies
The record number of gene, gene-modified cell therapies since last year and the recent approval of Gamida Cell’s Omisirge off-the-shelf allogeneic therapy raises an important question: How are other advanced …
Georgia Sloboda Engages with Experts to Share Expertise on Changing Vendor Quality Landscape
Quality oversight, regulatory perspective, and risk management in the changing vendor quality landscape are key topics of discussion at the FDA-NJPQCA Conference on May 23 in Kenilworth, New Jersey. The theme …
Thijs Beuming Discusses AlphaFold2 Models, Virtual Screening Campaigns in Newly Published Paper
Co-authored by Thijs Beuming, Ph.D., “Are Deep Learning Structural Models Sufficiently Accurate for Virtual Screening? Application of Docking Algorithms to AlphaFold2 Predicted Structures” was recently published in the Journal of …
Robert Huebner Discusses Developing the Next Generation of Influenza Vaccines in Newly Published Article
Written by Robert Huebner, Ph.D., “Leveraging modernization of the US influenza vaccine manufacturing base to make better vaccines: a work in progress” was recently published in Vaccine Insights. Dr. Huebner …
LBG Unites with Thought Leaders to Advance Pharma Industry
The power of science comes to life though innovation and cutting-edge technology at INTERPHEX 2023 in New York City on April 25 – 27. LBG’s Georgia Sloboda, Sri Venkatesan, Frank …
Sayan Paria Engages with Experts, Networks with Peers in Pharma Industry
Trending content from every aspect of the pharma supply chain takes front and center at CPHI North America in Philadelphia on April 25 – 27. LBG’s Sayan Paria, who is looking …
DJ Rezac and Kyle Kappeler Join Discussion, Share Insight about the CRO Industry
The complex contract research market is the focus of BioKansas’ symposium “Access to Research and Infrastructure: The Contract Research Industry.” LBG’s DJ Rezac, Ph.D. and Kyle Kappeler, Ph.D., who have …
